Insight

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Join biotech leaders, emerging innovators, investors and patient advocacy group reps for a candid, interactive and enlightening discussion about rare disease drug discovery and development.

Consumer products give new life to pharma

Consumer products give new life to pharma


Jan 13, 2017

The relevance of the consumer isn’t a new condition, but the role consumers play as companies make product development decisions may be.

Rare diseases, rare commitment

Rare diseases, rare commitment


Jan 11, 2017

Patients, their families and patient foundations are invaluable in helping drug developers understand the day-to-day realities of approx. 7,000 rare diseases (of which only 400...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 37,000 is constantly growing, and the partnering opportunities continually updating.